SIGA Reports 2025 Revenue Decline to $94.6M, Highlights $13M TPOXX Order & Strong Cash
SIGA is trading near its 52-week low of $4.95 (11% above the low).
Summary
SIGA Technologies reported 2025 revenues of $94.6 million and net income of $23.3 million. This news provides specific figures following an 8-K filing yesterday that broadly indicated a significant decline in 2025 financial results. The company also announced a new $13 million international procurement order for oral TPOXX, scheduled for delivery in 2026. Despite the revenue decline from $138.7 million in 2024, SIGA maintains a strong financial position with $155 million in cash and no debt. This mixed update provides specific details on the company's performance and future prospects, which traders would need to factor into their valuation.
At the time of this announcement, SIGA was trading at $5.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $392.1M. The 52-week trading range was $4.95 to $9.62. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.